TCT 2013: Higher pacemaker rate marks difference between Medtronic’s, Edwards Lifesciences’ TAVI devices

TCT 2013: Researchers find few differences between CoreValve and Sapien outcomes

Results from the PRAGMATIC Plus analysis of Edwards Lifesciences’ (NYSE:EW) Sapien transcatheter aortic valve implantation system and Medtronic’s (NYSE:MDT) rivaling CoreValve device found few differences between the devices, with the exception of lower rates of permanent pacemaker implantation in patients who received Edwards’ Sapien device.

The so-called "pacemaker issue" has been a recurring topic at healthcare conferences since 1st publication earlier this year in the Journal of the American College of Cardiology, although the problem isn’t considered a safety risk.

"Importantly, there is no association between pacemaker implants and increased mortality, while other complications – such as stroke, PVL, rupture, and vascular complications – are much more worrisome because they can be dangerous and even life-threatening for patients," Medtronic told MassDevice.com today.

Medtronic further noted that findings from the PRAGMATIC Plus study are less significant, given that the study is a non-randomized, retrospective analysis, unlike the more robust clinical studies released by Medtronic. The Minnesota medical device giant plans this week to release a highly anticipated 1st look at data from its U.S. CoreValve pivotal trial.

The pacemaker issue came up several times during TAVI presentations at today’s Transcatheter Cardiovascular Therapeutics symposium in San Francisco. The difference may be a meaningful one for physicians deciding which device to implant, given that the PRAGAMATIC Plus analysis found no other differences reported in 30-day or 1-year mortality or combined safety endpoints between CoreValve and Sapien, according to a morning presentation at TCT.

Findings from the PRAGMATIC Plus study, presented by the San Raffaele Scientific Institute’s Dr. Alaide Chieffo, included pooled clinical and procedural characteristics and outcome data for nearly 800 patients who received TAVI treatment prior to July 2011. Results showed no significant differences at 30 days in all-cause mortality, cardiac mortality, heart attack, stroke, life-threatening bleeding or other safety outcomes.

Researchers did, however, find a statistically significant difference in patients requiring permanent pacemaker implants, with 22.5% of CoreValve patients requiring pacemakers compared with only 5.9% of Sapien patients, an outcome that Dr. Chieffo said was unsurprising.

Luckily the pacemaker issue may be on the decline. Researchers last year released study results finding that post-TAVI pacemaker use, once reported in 1 out of every 3 CoreValve procedures, had dropped as physicians developed strategies to avoid problems during TAVI implantation.

Researchers gathered at last year’s PCR London Valves 2012 meeting reported several methods for combating the need for pacemaker implantation following a CoreValve procedure, including avoiding pre-dilation, positioning the valve slightly higher in the heart and waiting for 10 days following the procedure before determining whether a pacemaker is needed.

A Swedish TAVI study showed that post-procedure pacemaker use was down to 11%, with data coming from a registry that included both CoreValve and Sapien.

RSS From Medical Design & Outsourcing

  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]
  • MasterControl’s CEO talks EQMS software and new partnerships
    MasterControl offers a quality and compliance software that helps device companies speed time to market and improve their bottom lines. Under Jon’s leadership, the company has blossomed into a market leader and has a unique corporate culture that fosters growth, excellence and quality. In this podcast, MasterControl’s CEO, Jon Beckstrand, will discuss electronic quality management […]
  • BIT Group launches white label IVD solutions
    BIT Group has launched a product line of customizable IVD white label instruments. During recent years, BIT has invested capital and resources developing customizable, ready-to-use IVD systems to address a growing demand. “The IVD market is challenging for our clients,” said Marius Balger, CEO at BIT. “OEM’s must adhere to a growing number of evolving IVD […]
  • Toshiba expands line-up of ARM Cortex-M-based microcontrollers
    Toshiba announced that it has enhanced its current “TX Family” of ARM core-based microcontrollers and started to develop three series of microcontrollers, “TXZ0 series,” “TXZ3 series” and “TXZ4 series,” as part of the “TXZTM Family.” The TXZTM Family is a new collection of flash microcontrollers that support low-power consumption and high-speed operation for IoT and M2M […]
  • Parker Hannifin consolidates, layoffs ahead
    Parker Hannifin plans to consolidate a number of internal divisions, close 2 facilities and expand its Mexican operations, according to an internally distributed letter from Andy Ross, Parker’s engineered materials group president. The company has confirmed the letter was authentic, but has not disclosed how many employees will be affected by the new plans or […]
  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]
  • TSO3 begins shipment of STERIZONE VP4 Sterilizers to U.S.
    TSO3, a developer in sterilization technology for medical devices in healthcare settings, announced that the company has received purchase orders for multiple devices from the U.S. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and TSO3. “Finally,” said R.M. Rumble, president and CEO of TSO3. “Our Vision is […]
  • Turkish medical company is seeking reseller and OEM partners in the U.S.
    UZUMCU Medical Equipment, one of Turkey’s first and largest manufacturers of medical devices, is seeking reseller and OEM partners in the U.S. The company has an array of FDA-certified OR tables, surgical lights, surgical suction units, electro devices and other medical equipment. “We want to bring our experience with distributors throughout Europe and the Middle […]
  • QImaging introduces new CCD cameras for microscopy with modern software to streamline image capture
    QImaging, a manufacturer of scientific cameras for life science and OEM applications, introduces a new series of Retiga CCD cameras, accompanied by QImaging’s new acquisition software to deliver high-performance tools for microscopy and imaging to researchers at an affordable price. The new QImaging Retiga R1, Retiga R3 and Retiga R6 cameras offer valuable technical features […]

Leave a Reply